EMA ramps up measures to reduce animal testing

Going forward, a task force under the European Medicines Agency (EMA) will advise developers on how to minimize animal testing during drug development.

Photo: Torben Stroyer/ERH

Producers of new medicines will soon be able to receive free advice from the European Medicines Agency (EMA) on how to reduce animal testing when developing new medicines, the EMA writes in a statement.

The dialogs will be with a new taskforce, which the EMA has named the Innovation Task Force (ITF), which will be a unit spanning the entire agency, ensuring that the group has scientific, regulatory and legal competencies.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs